학술논문

A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine
Document Type
article
Source
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
Subject
African swine fever virus
adenovirus
infection
mucosal immunity
swine
vaccine
Infectious and parasitic diseases
RC109-216
Microbiology
QR1-502
Language
English
ISSN
22221751
2222-1751
Abstract
African swine fever (ASF) is an acute and highly contagious lethal infectious disease in swine that severely threatens the global pig industry. At present, a safe and efficacious vaccine is urgently required to prevent and control the disease. In this study, we evaluated the safety and immunogenicity of replication-incompetent type-2 adenoviruses carrying African swine fever virus (ASFV) antigens, namely CP204L (p30), E183L (p54), EP402R (CD2v), B646L (p72), and B602L (p72 chaperone). A vaccine cocktail delivered by simultaneous intramuscular (IM) and intranasal (IN) administration robustly elicited both systemic and mucosal immune responses against AFSV in mice and swine and provided highly effective protection against the circulating ASFV strain in farmed pigs. This multi-antigen cocktail vaccine was well tolerated in the vaccinated animals. No significant interference among antigens was observed. The combined IM and IN vaccination using this adenovirus-vectored antigen cocktail vaccine warrants further evaluation for providing safe and effective protection against ASFV infection and transmission.